Semaglutide Patient Reviews
Real semaglutide patient reviews and satisfaction data. 78% report significant appetite reduction. Common complaints, success patterns, and what to expect.
Avg. patient rating
7.5-8.2/10
Appetite reduction
~78% report
Food noise reduction
~65% report
GI complaint rate
~55% mention
12-month avg. loss
~15% body weight
Overall Patient Satisfaction
Semaglutide consistently ranks among the highest-rated weight loss medications in patient surveys. On major review platforms, it maintains an average rating of 7.5-8.2 out of 10. The majority of positive reviews highlight dramatic appetite reduction as the most notable effect, with many patients describing it as the first time they felt true freedom from food obsession.
Satisfaction rates are highest among patients who have reached and maintained their target dose for at least 3 months. Early discontinuation, often due to GI side effects during titration, accounts for most negative experiences. Patients who work with providers offering structured titration support report significantly better outcomes.
Common Praise Points
The most frequently cited benefits in patient reviews include: significant appetite reduction (mentioned in ~78% of positive reviews), reduced food noise or constant food-related thoughts (~65%), steady and predictable weight loss (~60%), improved energy levels as weight decreases (~45%), and better blood sugar control for those with prediabetes or diabetes (~40%).
Many patients report that semaglutide changed their relationship with food fundamentally. Rather than relying on willpower, they describe a natural decrease in hunger and reduced interest in overeating. Some patients also note improvements in related conditions like sleep apnea, joint pain, and blood pressure.
Common Complaints
The most frequent complaints center on GI side effects during titration, particularly nausea (mentioned in ~55% of negative reviews), cost and insurance barriers (~40%), supply shortages and difficulty obtaining refills (~30%), and the need for ongoing treatment to maintain results (~25%).
Some patients report dissatisfaction with the rate of weight loss, particularly if expectations were set unrealistically high. Clinical trial averages are just that, averages, and individual results vary widely. Patients who combine semaglutide with diet and exercise modifications consistently report better outcomes than those relying on medication alone.
Success Stories Framework
Patients who report the best outcomes tend to share several characteristics. They followed the full titration schedule without skipping doses or rushing dose increases. They made concurrent lifestyle changes including increased protein intake, regular physical activity, and adequate hydration. They had consistent provider support with regular check-ins.
Typical successful timelines: 5-8% weight loss by month 3, 10-12% by month 6, and 15%+ by month 12. Results vary based on starting weight, metabolic factors, adherence, and lifestyle modifications. The most satisfied patients set realistic expectations and treated semaglutide as one component of a comprehensive health strategy.
Switching and Comparison Reports
Patients who switched to semaglutide from liraglutide (Saxenda) most commonly cite the convenience of weekly vs. daily dosing and greater weight loss as the primary improvements. Those who switched from tirzepatide to semaglutide (or vice versa) report mixed experiences, with some preferring one over the other based on side effect profiles.
Patients comparing brand Wegovy to compounded semaglutide generally report similar efficacy, though some note differences in injection experience. The most important factor in satisfaction appears to be consistent access to medication rather than the specific source.
Frequently Asked Questions
How long does it take to see results on semaglutide?
Most patients notice appetite reduction within the first 1-2 weeks. Measurable weight loss typically begins by week 4-6. Average results at 3 months are 5-8% body weight loss, with continued progress over 12-18 months.
What percentage of people lose weight on semaglutide?
In the STEP 1 trial, approximately 86% of patients on Wegovy 2.4mg lost at least 5% of body weight, and about 50% lost 15% or more. Results in clinical practice may vary from trial data.
Do you regain weight after stopping semaglutide?
Studies show that most patients regain a significant portion of lost weight within 1-2 years of discontinuation. This is why many healthcare providers recommend ongoing treatment or a structured maintenance plan.
Is semaglutide worth the cost?
Value depends on individual circumstances. Patients who achieve significant weight loss and improvement in related health conditions often report that the health benefits justify the investment, particularly when insurance or compounded options reduce out-of-pocket costs.
Read verified provider reviews and compare patient satisfaction
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Semaglutide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.